CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Crystalline forms and pharmaceutical composition of a PRMT5 inhibitor of formula (I), methods of making PRMT5 inhibitor of formula (I) and crystalline forms thereof, methods of making the pharmaceutical compositions of the PRMT5 inhibitor of formula (I) and methods of using the PRMT5 inhibitor of fo...

Full description

Saved in:
Bibliographic Details
Main Authors Ronn, Magnus, Li, Hongming, Tonini, Matthew Robert, Cottrell, Kevin M, Zhang, Minjie, Tsai-Marie, Alice Wanjung, Garad, Sapna Makhija, Liang, Jianglin, Wilker, Erik William, Briggs, Kimberly Jane
Format Patent
LanguageEnglish
Published 22.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Crystalline forms and pharmaceutical composition of a PRMT5 inhibitor of formula (I), methods of making PRMT5 inhibitor of formula (I) and crystalline forms thereof, methods of making the pharmaceutical compositions of the PRMT5 inhibitor of formula (I) and methods of using the PRMT5 inhibitor of formula (I) or crystalline solid forms and pharmaceutically acceptable compositions thereof.
Bibliography:Application Number: US202218083222